Access cutting-edge skin infections treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.
Access skin infections specialists in Tampa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related skin infections treatment provided free
This protocol describes a randomized, open-label study to evaluate the safety and tolerability of 2 formulations of single-dose intravenous (IV) oritavancin diphosphate (Orbactiv and Kimyrsa) for the treatment of pediatric participants with acute bacterial skin and skin structure infections (ABSSSIs). This study involves 2 oritavancin products, Orbactiv and Kimyrsa. Oritavancin is the active drug substance in both Orbactiv and Kimyrsa. This study protocol distinguishes the differences between O
Sponsor: Melinta Therapeutics, LLC
Check if you qualify for this skin infections clinical trial in Tampa, FL
If you're searching for skin infections treatment options in Tampa, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced skin infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.